Rheumatology News Roundup: Is it axSpA or fibromyalgia?

In this week's news roundup from Rheumatology Network, we feature a series of studies that focus on new treatments for rheumatic disease. We also highlight the newly approved secukinumab (Cosentyx, Novartis) for active non-radiographic axial spondyloarthritis (axSpA). Today, we feature a discussion with Dr. Alexis Ogdie-Beatty and Kelly Gavigan, the lead researcher on a recent study about the overlap between axSpA and fibromyalgia.

The study was presented at the EULAR e-Congress held online earlier this month.

In this interview, Dr. Ogdie, of Penn Medicine, and Ms. Gavigan, of the Global Healthy Living Foundation, discuss the overlap between fibromyalgia symptoms and axSpA.

Related Videos
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
© 2025 MJH Life Sciences

All rights reserved.